POM vs SER
Comparison between Pomdoctor Ltd (POM, Company) and AgeX Therapeutics Inc (SER, Company).
Both POM and SER are from the Healthcare sector.
POM vs SER - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
POM
$31M
SER
$31M
Max Drawdown
Winner
POM
98.82%
SER
99.35%
Sharpe Ratio
POM
-0.23
Winner
SER
-0.22
5Y Beta
POM
0.69
Winner
SER
0.28
Industry
POM
Pharmaceutical Retailers
SER
Biotechnology
P/E Ratio
POM
N/A
SER
-1.14
PEG Ratio
POM
N/A
SER
-0.00
5Y EPS CAGR
POM
N/A
SER
-28.62%
Debt to Equity
POM
N/A
SER
0.00%
Free Cash Flow Yield
POM
N/A
SER
-58.44%
P/S Ratio
POM
0.09
SER
N/A
P/B Ratio
POM
-0.01
SER
N/A
POM vs SER - Historical Returns
Returns include dividend reinvestment.
1M
POM
-38.96%
Winner
SER
+39.07%
3M
POM
-81.61%
Winner
SER
+64.06%
6M
POM
-76.53%
Winner
SER
-20.96%
1Y
POM
N/A
SER
-63.48%
5Y(CAGR)
POM
N/A
SER
-47.62%
Max(CAGR)
POM
-99.70%
Winner
SER
-39.79%
POM vs SER - Annual Returns (2018 - 2026)
Returns include dividend reinvestment.
| Year | POM | SER |
|---|---|---|
| 2026 | -77.94% | +1.06% |
| 2025 | -92.68% | -62.49% |
| 2024 | N/A | -66.51% |
| 2023 | N/A | -31.13% |
| 2022 | N/A | -41.91% |
| 2021 | N/A | -31.01% |
| 2020 | N/A | -22.05% |
| 2019 | N/A | -39.33% |
| 2018 | N/A | +10.33% |
POM vs SER Drawdown Comparison
The maximum drawdown for POM was -98.82%, occurring on Jun 18, 2026. This drawdown has not yet recovered.
The maximum drawdown for SER was -99.35%, occurring on Mar 18, 2026. This drawdown has not yet recovered.
The current POM drawdown is -98.82%. The current SER drawdown is -98.93%.
| Rank | POM | SER |
|---|---|---|
| #1 | -98.82% Nov 6, 2025 - Jun 18, 2026 | -99.35% Dec 3, 2018 - Mar 18, 2026 |
| #2 | -12.37% Oct 9, 2025 - Oct 28, 2025 | N/A |
| #3 | -0.73% Oct 30, 2025 - Nov 3, 2025 | N/A |
Correlation
Correlation between POM and SER is 0.93 which considered as a very strong positive correlation - the stocks move almost identically together.
0.93
-101
Select Stocks to Compare
Popular: POM vs SPYSER vs SPY
More Comparisons
Compare with similar stocks